Abstract
SUMOylation is an essential modification that regulates hundreds of proteins in eukaryotic cells. Owing to its dynamic nature and low steady-state levels, endogenous SUMOylation is challenging to detect. Here, we present a method that allows efficient enrichment and identification of endogenous targets of SUMO1 and the nearly identical SUMO2 and 3 (SUMO 2/3) from vertebrate cells and complex organ tissue. Using monoclonal antibodies for which we mapped the epitope, we enriched SUMOylated proteins by immunoprecipitation and peptide elution. We used this approach in combination with MS to identify SUMOylated proteins, which resulted in the first direct comparison of the endogenous SUMO1- and SUMO2/3-modified proteome in mammalian cells, to our knowledge. This protocol provides an affordable and feasible tool to investigate endogenous SUMOylation in primary cells, tissues and organs, and it will facilitate understanding of SUMO's role in physiology and disease.
Similar content being viewed by others
References
Geiss-Friedlander, R. & Melchior, F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947–956 (2007).
Gareau, J.R. & Lima, C.D. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861–871 (2010).
Kho, C. et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 477, 601–605 (2011).
Bertolotto, C. et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480, 94–98 (2011).
Datwyler, A.L. et al. SUMO2/3 conjugation is an endogenous neuroprotective mechanism. J. Cereb. Blood Flow Metab. 31, 2152–2159 (2011).
Lee, Y.J. & Hallenbeck, J.M. Insights into cytoprotection from ground squirrel hibernation, a natural model of tolerance to profound brain oligaemia. Biochem. Soc. Trans. 34, 1295–1298 (2006).
Lee, Y.J. et al. Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J. Cereb. Blood Flow Metab. 27, 950–962 (2007).
Conti, L., Kioumourtzoglou, D., O'Donnell, E., Dominy, P. & Sadanandom, A. OTS1 and OTS2 SUMO proteases link plant development and survival under salt stress. Plant Signal. Behav. 4, 225–227 (2009).
Desterro, J.M., Rodriguez, M.S. & Hay, R.T. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2, 233–239 (1998).
Hong, Y. et al. SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability. PLoS ONE 6, e23046 (2011).
Muller, S. et al. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275, 13321–13329 (2000).
Rodriguez, M.S. et al. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455–6461 (1999).
Kjenseth, A. et al. The gap junction channel protein connexin43 is covalently modified and regulated by SUMOylation. J. Biol. Chem. 287, 15851–15861 (2012).
Ismail, I.H. et al. CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage. Nucleic Acids Res. 40, 5497–5510 (2012).
Yu, J. et al. RhoGDI SUMOylation at K138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility. J. Biol. Chem. 287, 13752–13760 (2012).
Vertegaal, A.C. et al. A proteomic study of SUMO-2 target proteins. J. Biol. Chem. 279, 33791–33798 (2004).
Vertegaal, A.C. et al. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell Proteomics 5, 2298–2310 (2006).
Matic, I. et al. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol. Cell 39, 641–652 (2010).
Galisson, F. et al. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol. Cell Proteomics 10, M110.004796 (2011).
Zhao, Y., Kwon, S.W., Anselmo, A., Kaur, K. & White, M.A. Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrate proteins. J. Biol. Chem. 279, 20999–21002 (2004).
Blomster, H.A. et al. Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites. Mol. Cell Proteomics 8, 1382–1390 (2009).
Yang, W. et al. Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics. J. Proteome Res. 11, 1108–1117 (2012).
Hoege, C., Pfander, B., Moldovan, G.L., Pyrowolakis, G. & Jentsch, S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135–141 (2002).
Zhou, W., Ryan, J.J. & Zhou, H. Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J. Biol. Chem. 279, 32262–32268 (2004).
Denison, C. et al. A proteomic strategy for gaining insights into protein sumoylation in yeast. Mol. Cell Proteomics 4, 246–254 (2005).
Panse, V.G., Hardeland, U., Werner, T., Kuster, B. & Hurt, E. A proteome-wide approach identifies sumoylated substrate proteins in yeast. J. Biol. Chem. 279, 41346–41351 (2004).
Kaminsky, R. et al. SUMO regulates the assembly and function of a cytoplasmic intermediate filament protein in C. elegans. Dev. Cell 17, 724–735 (2009).
Nie, M., Xie, Y., Loo, J.A. & Courey, A.J. Genetic and proteomic evidence for roles of Drosophila SUMO in cell cycle control, Ras signaling, and early pattern formation. PLoS ONE 4, e5905 (2009).
Miller, M.J., Barrett-Wilt, G.A., Hua, Z. & Vierstra, R.D. Proteomic analyses identify a diverse array of nuclear processes affected by small ubiquitin-like modifier conjugation in Arabidopsis. Proc. Natl. Acad. Sci. USA 107, 16512–16517 (2010).
Golebiowski, F. et al. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2, ra24 (2009).
Saitoh, H. & Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252–6258 (2000).
Bruderer, R. et al. Purification and identification of endogenous polySUMO conjugates. EMBO Rep. 12, 142–148 (2011).
Matunis, M.J., Coutavas, E. & Blobel, G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457–1470 (1996).
Zhang, X.D. et al. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis. Mol. Cell 29, 729–741 (2008).
Einhauer, A. & Jungbauer, A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J. Biochem. Biophys. Methods 49, 455–465 (2001).
Field, J. et al. Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol. Cell Biol. 8, 2159–2165 (1988).
Hopp, T.P. et al. A short polypeptide marker sequence useful for recombinant protein identification and purification. Nat. Biotechnol. 6, 1204–1210 (1988).
Mahajan, R., Delphin, C., Guan, T., Gerace, L. & Melchior, F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97–107 (1997).
Sternsdorf, T., Jensen, K. & Will, H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621–1634 (1997).
Lee, Y.K., Thomas, S.N., Yang, A.J. & Ann, D.K. Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells. J. Biol. Chem. 282, 1595–1606 (2007).
Knipscheer, P. et al. Ubc9 sumoylation regulates SUMO target discrimination. Mol. Cell 31, 371–382 (2008).
Zhou, A., Ou, A.C., Cho, A., Benz, E.J. Jr. & Huang, S.C. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5′ splice site selection. Mol. Cell Biol. 28, 5924–5936 (2008).
Ueda, J., Tachibana, M., Ikura, T. & Shinkai, Y. Zinc finger protein Wiz links G9a/GLP histone methyltransferases to the co-repressor molecule CtBP. J. Biol. Chem. 281, 20120–20128 (2006).
Shan, S.F. et al. Modulation of transcriptional corepressor activity of prospero-related homeobox protein (Prox1) by SUMO modification. FEBS Lett. 582, 3723–3728 (2008).
Evdokimov, E., Sharma, P., Lockett, S.J., Lualdi, M. & Kuehn, M.R. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. J. Cell Sci. 121, 4106–4113 (2008).
Reverter, D. & Lima, C.D. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 435, 687–692 (2005).
Tatham, M.H. et al. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat. Struct. Mol. Biol. 12, 67–74 (2005).
Zhu, J. et al. Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification. J. Biol. Chem. 283, 29405–29415 (2008).
Meulmeester, E., Kunze, M., Hsiao, H.H., Urlaub, H. & Melchior, F. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Mol. Cell 30, 610–619 (2008).
Zhu, S. et al. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1. Mol. Cell 33, 570–580 (2009).
Werner, A., Flotho, A. & Melchior, F. The RanBP2/RanGAP1(*)SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase. Mol. Cell 46, 287–298 (2012).
Pichler, A., Gast, A., Seeler, J.S., Dejean, A. & Melchior, F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109–120 (2002).
Lallemand–Breitenbach, V. et al. Arsenic degrades PML or PML-RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10, 547–555 (2008).
Shevchenko, A., Tomas, H., Havlis, J., Olsen, J.V. & Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856–2860 (2006).
Hsiao, H.H., Meulmeester, E., Frank, B.T., Melchior, F. & Urlaub, H. “ChopNSpice,” a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides. Mol. Cell Proteomics 8, 2664–2675 (2009).
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
Perkins, D.N., Pappin, D.J., Creasy, D.M. & Cottrell, J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551–3567 (1999).
Nikolov, M. et al. Chromatin affinity purification and quantitative mass spectrometry defining the interactome of histone modification patterns. Mol. Cell Proteomics 10, M110.005371 (2011).
Acknowledgements
We gratefully acknowledge M. Matunis (Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA) for making hybridomas for monoclonal anti-SUMO antibodies available to the community and H. de Thé (Université Paris Diderot, Sorbonne Paris Cité, Hôpital St. Louis 1, Paris, France) for generously providing anti-PML antibodies, R. Ramaker and N. Stankovic for help with antibody characterization and all lab members for sharing reagents and advice. This work was supported by the Deutsche Forschungsgemeinschaft (SPP1365, ME 2279/3 to F.M.) and the EU Network of Excellence Rubicon (to F.M.) and by fellowships of the Excellence Cluster CellNetworks (to S.V.B.) and the Deutsche Krebshilfe (to S.H.).
Author information
Authors and Affiliations
Contributions
J.B. and S.V.B. designed and carried out most experiments and wrote the manuscript. C.D. carried out experiments and wrote the manuscript. S.K., H.-H.H. and H.U. carried out MS and data analyses. M.B.D. and S.H. helped with mouse liver experiments. F.M. guided the project, designed experiments and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1 and 2 (PDF 2237 kb)
Data set
Supplementary Table 1 (XLSX 491 kb)
Data set
Supplementary Table 2 (XLSX 223 kb)
Rights and permissions
About this article
Cite this article
Becker, J., Barysch, S., Karaca, S. et al. Detecting endogenous SUMO targets in mammalian cells and tissues. Nat Struct Mol Biol 20, 525–531 (2013). https://doi.org/10.1038/nsmb.2526
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.2526
- Springer Nature America, Inc.
This article is cited by
-
Hypoxia-driven deSUMOylation of EXOSC10 promotes adaptive changes in the transcriptome profile
Cellular and Molecular Life Sciences (2024)
-
SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells
Cellular & Molecular Biology Letters (2024)
-
N-terminal α-amino SUMOylation of cofilin-1 is critical for its regulation of actin depolymerization
Nature Communications (2023)
-
DAXX drives de novo lipogenesis and contributes to tumorigenesis
Nature Communications (2023)
-
Exploration of nuclear body-enhanced sumoylation reveals that PML represses 2-cell features of embryonic stem cells
Nature Communications (2022)